Cision PR Newswire

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....

VCI BIOFUELS GROUP SIGNS DEFINITIVE MERGER AGREEMENT WITH INTERNATIONAL MEDIA ACQUISITION CORP. TO PUBLICLY LIST ON THE NASDAQ

NEW YORK, April 10, 2025 /PRNewswire/ -- The Vietnamese ethanol production company, Vietnam Biofuels Development Joint Stock Company and its affiliates (together, "Vietnam Biofuels"...

Creality Celebrates 11th Anniversary with New Visual Identity and 3D Printing Innovations

DETROIT, April 10, 2025 /PRNewswire/ -- Creality, a leading global 3D printing technology brand, celebrated its 11th anniversary at the Renaissance Center of Detroit...

PRIVATEER’S GLOBAL EXPANSION CONTINUES WITH STRATEGIC INVESTMENT FROM TAIWAN’S FAR EASTERN GROUP

KIHEI, Hawaii, April 10, 2025 /PRNewswire/ -- Privateer, a leader in geospatial intelligence and space sustainability, today announced a strategic investment from Far Eastern...

Xiao‑I Corporation Crosses into Profitability on Run‑Rate Basis; Pre‑Announces 2024 Revenue Up 19% and Guides to Full‑Year Profit in 2025

Margin expansion from Hua Zang LLM MaaS and AI hardware sets the stage for sustainable earnings growth SHANGHAI, April 9, 2025 /PRNewswire/ -- Xiao‑I Corporation...